ESC 365 - What is the optimal timing of administration of P2Y12 inhibitor in STEMI?

ACVC Premium Access

What is the optimal timing of administration of P2Y12 inhibitor in STEMI?

Session: Optimisation of STEMI treatment

Topic: Acute Coronary Syndromes: Antiplatelet Agents

Speaker: Professor U. Zeymer (Ludwigshafen, DE)

Event: Acute Cardiovascular Care 2018

Congress Presentation

Add to my library

About the speaker

Professor Uwe Zeymer

Klinikum Ludwigshafen, Ludwigshafen (Germany)

18 presentations

3 followers

4 more presentations in this session

Difficult ECG diagnosis in STEMI – case presentation.

Speaker: Professor C. Vrints (Antwerp, BE)

Do we treat too many patients with primary PCI instead of fibrinolysis?

Speaker: Professor N. Danchin (Paris, FR)

Safe discharge early after STEMI: what's the evidence?

Speaker: Doctor M. Lenzen (Rotterdam, NL)

Higher mortality during weekend admission for acute coronary syndromes: still a matter of concern

Speaker: Doctor G. Malanchini (Bergamo, IT)

Access the full session

Optimisation of STEMI treatment

Speakers: Professor U. Zeymer, Professor C. Vrints, Professor N. Danchin, Doctor M. Lenzen, Doctor G. Malanchini

About the event

Acute Cardiovascular Care 2018

3 March - 5 March 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources